Showing results (41-50 of 98) with videos related to

Sort By:
Pageof 10
The Journal of Pathology|December 16, 2017
Nrf2 promotes oesophageal cancer cell proliferation via metabolic reprogramming and detoxification of reactive oxygen speciesYuki Kitano, Yoshifumi Baba, Shigeki Nakagawa, et al.
World Journal of Hepatology|February 7, 2022
Assessment for the minimal invasiveness of laparoscopic liver resection by interleukin-6 and thrombospondin-1Takayoshi Kaida, Hiromitsu Hayashi, Hiroki Sato, et al.
World Journal of Surgery|May 2, 2019
Sarcopenia Affects Systemic and Local Immune System and Impacts Postoperative Outcome in Patients with Extrahepatic CholangiocarcinomaYuki Kitano, Yo-Ichi Yamashita, Yoichi Saito, et al.
World Journal of Gastrointestinal Surgery|September 13, 2021
Borderline resectable for colorectal liver metastases: Present status and future perspectiveYuki Kitano, Hiromitsu Hayashi, Takashi Matsumoto, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|November 20, 2023
Neoadjuvant chemotherapy for borderline resectable colorectal cancer liver metastases: a single-institution retrospective studyYuki Kitano, Yoshihiro Ono, Kosuke Kobayashi, et al.
Clinical Transplantation|July 21, 2020
Early- and long-term outcomes of liver transplantation with rescue allocation graftsYuki Kitano, Marc-Antoine Allard, Shinichiro Nakada, et al.
Annals of Surgical Oncology|June 26, 2023
Prognostic Impact of Tumor Markers (CEA and CA19-9) on Patients with Resectable Colorectal Liver Metastases Stratified by Tumor Number and Size: Potentially Valuable Biologic Markers for Preoperative TreatmentKosuke Kobayashi, Yoshihiro Ono, Yuki Kitano, et al.
Annals of Surgical Oncology|May 4, 2023
Clinical Efficacy of Neoadjuvant Chemotherapy with Gemcitabine plus S-1 for Resectable Pancreatic Ductal Adenocarcinoma Compared with Upfront SurgeryYuki Kitano, Yosuke Inoue, Tsuyoshi Takeda, et al.
Pancreas|April 1, 2026
Neoadjuvant Chemotherapy Diminishes Ki-67 Overexpression and Persistent Overexpression is a Poor Prognostic Factor in Pancreatic Ductal Adenocarcinoma After PancreatectomyShinsei Yumoto, Hiromitsu Hayashi, Toru Takematsu, et al.
Anticancer Research|May 29, 2017
Effects of Preoperative Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios on Survival in Patients with Extrahepatic CholangiocarcinomaYuki Kitano, Yo-Ichi Yamashita, Kensuke Yamamura, et al.
Pageof 10